SERACENI, Silva
 Distribuzione geografica
Continente #
NA - Nord America 4.319
EU - Europa 2.732
AS - Asia 787
AF - Africa 12
OC - Oceania 8
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.867
Nazione #
US - Stati Uniti d'America 4.314
IT - Italia 1.280
CN - Cina 519
UA - Ucraina 390
PL - Polonia 266
DE - Germania 244
TR - Turchia 222
GB - Regno Unito 163
SE - Svezia 97
FI - Finlandia 94
FR - Francia 90
AT - Austria 23
BE - Belgio 19
RU - Federazione Russa 17
AL - Albania 11
IN - India 11
VN - Vietnam 9
AU - Australia 8
IR - Iran 7
NL - Olanda 7
CH - Svizzera 6
RO - Romania 6
HK - Hong Kong 5
IE - Irlanda 5
BG - Bulgaria 4
BR - Brasile 4
JP - Giappone 4
KR - Corea 3
MG - Madagascar 3
CA - Canada 2
CD - Congo 2
CO - Colombia 2
DK - Danimarca 2
EU - Europa 2
HU - Ungheria 2
SG - Singapore 2
SM - San Marino 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
LU - Lussemburgo 1
MA - Marocco 1
MZ - Mozambico 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
TW - Taiwan 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 7.867
Città #
Woodbridge 519
Fairfield 429
Chandler 417
Jacksonville 407
Houston 345
Ashburn 279
Warsaw 264
Ann Arbor 255
Wilmington 191
Izmir 162
Cambridge 141
Seattle 130
Nanjing 116
Beijing 100
Milan 90
Princeton 86
Ferrara 80
Boardman 71
Shanghai 50
Dearborn 49
Rome 49
New York 38
Addison 37
San Diego 34
Hebei 33
Nanchang 32
Falls Church 31
Shenyang 30
Redwood City 28
Jiaxing 27
Bremen 26
Changsha 24
San Mateo 23
Norwalk 22
Vienna 21
Mountain View 18
Tianjin 18
Brussels 17
Helsinki 17
Verona 14
Los Angeles 13
Washington 12
Zhengzhou 12
Bologna 11
Jinan 11
Andover 10
Dong Ket 9
Florence 9
Hangzhou 9
Kunming 9
Orange 9
Padova 9
Turin 9
Catania 8
Dallas 8
Ningbo 8
Cagliari 7
Des Moines 7
Guangzhou 7
Naples 7
Torino 7
Busto Arsizio 6
Castelnuovo Rangone 6
Genoa 6
Indiana 6
London 6
Ancona 5
Auburn Hills 5
Brescia 5
Feltre 5
Genova 5
Lanzhou 5
Martinsicuro 5
Mumbai 5
Palermo 5
Redmond 5
Taizhou 5
Changchun 4
Hefei 4
Hong Kong 4
Messina 4
Tokyo 4
Trieste 4
Acireale 3
Bangalore 3
Busalla 3
Campobasso 3
Chicago 3
Como 3
Elbasan 3
Ercolano 3
Jesi 3
Latina 3
L’Aquila 3
Martellago 3
Modena 3
Monopoli 3
Pescara 3
Piombino 3
Pisa 3
Totale 5.071
Nome #
SCHISTOSOMIASI URINARIA CON SEVERA EMATURIA IN UN SOGGETTO GHANESE. DESCRIZIONE DI UN CASO CLINICO 514
Osteomieliti da gram negativi difficili:problematiche di antibiotico terapia in 3 casi clinici. 490
Endocardite da Bartonella henselae? Riscontro di anticorpi anti-fosfolipidi, anti-beta2-glicoproteina e anti-cardiolipina. 486
Molecular epidemiology of HPV and Chlamydia trachomatis pathogenic agents in a large cohort of women from a North-East Italian area: prevalence and distribution of HPV genotypes in the setting of co-infection with Chlamydia trachomatis 180
Investigation on silent bacterial infections in specimens from pregnant women affected by spontaneous miscarriage 161
Influence of Vaginal Lactoferrin Administration on Amniotic Fluid Cytokines and its Role Against Inflammatory Complications of Pregnancy 159
Evaluation of a Real-time PCR-based assay using the lightcycler system for. detection of Toxoplasma gondii bradyzoite genes in blood specimens from patients with toxoplasmic retinochoroiditis 142
Identification of Chlamydia trachomatis in a patient with ocular lymphoma 139
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 126
INDAGINE RETROSPETTIVA DELLE LINFOADENOPATIE INFETTIVE. RUOLO DEI TESTS MOLECOLARI. 119
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 119
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 116
Chorionic Tissue and Peripheral Blood as Potential Reservoir of Pathogens Responsible of Reccurent Spontaneous Miscarriage in Women. Preliminary Results 114
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 112
Expression of toxoplasmic 65 kDa cystic mRNA by RT-PCR in patients with Toxoplasma gondii infection relapses 111
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 111
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 110
Leptin/adiponectin ratio predicts post-stroke neurological outcome 109
null 103
null 102
Detection of clinical-stage specific molecular Toxoplasma gondii gene patterns in patients with toxoplasmic lymphadenitis 98
null 97
Efficacy of a novel reverse transcriptase-polymerase chain reaction (RT-PCR) for detecting Toxoplasma gondii bradyzoite gene expression in human clinical specimens 95
INFEZIONI DEL SISTEMA NERVOSO CENTRALE E CHLAMYDIA PNEUMONIAE. RUOLO ETIOPATOGENETICO NELLA SCLEROSI MULTIPLA 95
Symptomatic carotid atherosclerotic plaques in surgical patients: evalutation of a possibile link with Chlamydia pneumoniae. 92
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 90
null 90
null 87
Investigation of Chlamydia pneumonite and Mycoplasma spp. In clinical specimens from patients with arhritis 85
Quantificazione mediante Real-time PCR di geni di Toxoplasma gondii in pazienti AIDS con encefalite toxoplasmica (ET) riattivata 85
null 85
null 84
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 84
Analysis of Chlamydia and Mycoplasma Expression in Atherosclerotic plaques and its Relation with P2X7 and TLR Expression 84
null 83
null 80
Cultural and molecular isolation of Chlamydophila pneumoniae from patients with joint disease. Pathogenic and diagnostic perspectives. 79
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 79
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 77
Identification of metabolically active Chlamydia pneumoniae in symptomatic carotid atherosclerotic plaques. 77
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 75
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 75
COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions 74
Detection of Parachlamydialike organisms in patients with multiple sclerosis. 73
Identificazione e quantificazione molecolare di Ureaplasma Spp su secrezioni respiratorie di neonati prematuri con RDS. Risultati preliminari 73
Biomolecular and immunological diagnostic aspects of toxoplasmosis during AIDS. 70
Bipolar Disorder With Psychotic Features and Ocular Toxoplasmosis 70
null 68
Analysis of Th1/Th2 Cytokine Profiles in Human Cd4 T Repertoire Specific for Pneumocystis 67
Identificazione di Micoplasmi e Clamide in pazienti con febbre indeterminata. 66
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 66
Investigation of cytokines and intracellular bacteria in relation to the administration of lactoferrin in women with infertility 66
null 66
null 66
Successful isolation of Chlamydia pneumoniae from synovial fluid and blood cultures of a patient with undifferentiated spondyloarthopathy. 65
Under the microscope: Focusing on Chlamydia pneumoniae infection and Multiple Sclerosis 64
Chlamydia pneumonia-specific CFS-restricted oligoclonal IgG bands are associated to a subset of patients with prosessive forms of multiple sclerosis. 62
Unusual Mycoplasma detection in PBMCs of patients with underfined fever. 61
Chlamydia trachomatis and Ocular Lynphoma. a possible link? 59
Investigation of Toxoplasma gondii in shellfish from Adriatic Sea, Italy 58
Asymptomatic Toxoplasma gondii infection in liver transplant patients 58
Chlamydie ed Artropatie. Un possibile ruolo? 57
CULTURAL AND HIGHLY SENSITIVE MOLECULAR TECHNIQUES FOR DETECTION OF CHLAMYDIA PNEUMONIAE IN SYNOVIAL FLUID AND BLOOD SPECIMENS FROM PATIENTS WITH CHRONIC SYNOVITIS 57
Infezioni dell’osso e dei tessuti molli nelle fratture esposte. Approcci diagnostici e terapeutici. 57
The role of Chlamydia infection in reactive arthritis. A case report. 57
Unexplained cases of CNS disorders with evidence of Chlamydia pneumoniae DNA 56
Role of Toll-like receptors in patients with multiple sclerosis and Chlamydophila pneumoniae infection 56
EVIDENCE OF CHLAMYDOPHILA PNEUMONIAE AND HUMAN HERPESVIRUS 8 IN A PATIENT WITH PRIMARY CUTANEOUS ANAPLASTIC LARGE-CELL LYMPHOMA 56
Evidence of cerebrospinal fluid free kappa light chains in AIDS patients with Toxoplasma gondii encephalitis 54
Detection of Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response in a subset of patients with progressive forms of multiple sclerosis 54
null 53
Expression of Toxoplasmic 65 kDa Cystic mRNA by RT-PCR in Patients with Toxoplasma gondii Relapses 51
Identification of Chlamydophila pneumoniae heat shock protein 60 on atherosclerotic carotid plaque by RT-PCR 51
Possibile impiego terapeutico di Ivermectina nel trattamento dell’idatidosi. Descrizione di un caso clinico. 50
Linfoadenite toxoplasmatica: approccio diagnostico biomolecolare nell'immunocompetente 49
Role of Chlamydia in the Development of Ocular Adnexal Lymphoma 47
The role of Ureaplasma urealyticum/U. parvum in preterm infants with respiratory distress syndrome. Diagnostic and prognostic value of molecular techniques 46
null 45
Evidence of Chlamydophila pneumoniae and human herpesvirus 8 in a patient with primary cutaneous anaplastic large-cell lymphoma. 44
Molecular markers to evaluate stage conversion of Toxoplasma gondii in recrudescence of Toxoplasmosis in immunocompetent host. 42
Ruolo di trail nella patogenesi del danno neuronale indotto dalla proteina Tat di HIV-1 36
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 31
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 30
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 26
Vaginal Lactoferrin Administration before Genetic Amniocentesis Decreases Amniotic Interleukin-6 Levels. 21
Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis 20
Acute Prosthetic Joint Infections with Poor Outcome Caused by Staphylococcus Aureus Strains Producing the Panton-Valentine Leukocidin 16
Chlamydophila pneumoniae infection and its role in neurological disorders. 16
MOLECULAR EVIDENCE OF CHLAMYDIA TRACHOMATIS IN A FEMALE PATIENT WITH OCULAR LYMPHOMA AND CHRONIC HEPATITIS B. 13
Detection of Chlamydophila pneumoniae in patients with arthritis: significance and diagnostic value 12
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 10
Chlamydophila pneumoniae DNA and mRNA transcript levels in peripheral blood mononuclear cells and cerebrospinal fluid of patients with multiple sclerosis 9
Molecular detection of Parachlamydia-like organisms in cerebrospinal fluid of patients with "multiple sclerosis" 9
High prevalence of hpv multiple genotypes in women with persistent chlamydia trachomatis infection 8
Molecular identification and antibody testing of Chlamydophila pneumoniae in a subgroup of patients with HIV-associated dementia complex. Preliminary results 5
Totale 7.995
Categoria #
all - tutte 23.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019532 0 0 0 0 0 0 0 0 0 0 170 362
2019/20201.578 282 70 51 198 96 170 137 160 99 183 85 47
2020/20211.207 116 102 57 123 81 120 41 126 62 163 141 75
2021/2022962 49 118 65 42 39 52 40 53 26 76 98 304
2022/20231.026 90 73 45 129 178 141 66 103 93 16 58 34
2023/2024616 49 66 62 41 75 91 51 83 43 49 6 0
Totale 7.995